These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34120432)

  • 1. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
    Lin Y; Yu T; Li H; Yin Z; Guo A
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
    Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
    Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases.
    Li H; Xia M; Zheng S; Lin Y; Yu T; Xie Y; Shen Y; Liu X; Qian X; Yin Z
    Biotechnol Genet Eng Rev; 2024 Apr; 40(1):359-380. PubMed ID: 36852928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
    Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
    J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of 
Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases].
    Gao N; Teng C; Fan C; Xin T
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
    Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
    Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
    Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
    Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted metabolomics analysis of cerebrospinal fluid in patients with leptomeningeal metastases from non-small cell lung cancer.
    Li H; Lin Y; Zheng S; Yu T; Xie Y; Yin Z
    Biotechnol Genet Eng Rev; 2024 Oct; 40(2):815-832. PubMed ID: 36942709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
    Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H
    J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
    Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of leptomeningeal metastasis in solid tumors.
    Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
    Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal metastasis: Clinical experience of 519 cases.
    Hyun JW; Jeong IH; Joung A; Cho HJ; Kim SH; Kim HJ
    Eur J Cancer; 2016 Mar; 56():107-114. PubMed ID: 26841095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
    Vinayanuwattikun C; Mingmalairak S; Jittapiromsak N; Thaipisuttikul I; Sriuranpong V; Mutirangura A; Shuangshoti S
    J Neurooncol; 2016 Sep; 129(3):395-403. PubMed ID: 27401153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
    Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
    Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
    Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
    Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.